Ling Li1, Shichao Pang1, Lingyao Zeng1, Ulrich Güldener1, Heribert Schunkert2,3. 1. Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Lazarettstr. 36, 80636, Munich, Germany. 2. Department of Cardiology, Deutsches Herzzentrum München, Technische Universität München, Lazarettstr. 36, 80636, Munich, Germany. schunkert@dhm.mhn.de. 3. Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), Munich Heart Alliance, Munich, Germany. schunkert@dhm.mhn.de.
Abstract
BACKGROUND: Epidemiological studies have shown inverse association between intelligence and coronary artery disease (CAD) risk, but the underlying mechanisms remain unclear. METHODS: Based on 242 SNPs independently associated with intelligence, we calculated the genetic intelligence score (gIQ) for participants from 10 CAD case-control studies (n = 34,083) and UK Biobank (n = 427,306). From UK Biobank, we extracted phenotypes including body mass index (BMI), type 2 diabetes (T2D), smoking, hypertension, HDL cholesterol, LDL cholesterol, measured intelligence score, and education attainment. To estimate the effects of gIQ on CAD and its related risk factors, regression analyses was applied. Next, we studied the mediatory roles of measured intelligence and educational attainment. Lastly, Mendelian randomization was performed to validate the findings. RESULTS: In CAD case-control studies, one standard deviation (SD) increase of gIQ was related to a 5% decrease of CAD risk (odds ratio [OR] of 0.95; 95% confidence interval [CI] 0.93 to 0.98; P = 4.93e-5), which was validated in UK Biobank (OR = 0.97; 95% CI 0.96 to 0.99; P = 6.4e-4). In UK Biobank, we also found significant inverse correlations between gIQ and risk factors of CAD including smoking, BMI, T2D, hypertension, and a positive correlation with HDL cholesterol. The association signals between gIQ and CAD as well as its risk factors got largely attenuated after the adjustment of measured intelligence and educational attainment. The causal role of intelligence in mediating CAD risk was confirmed by Mendelian randomization analyses. CONCLUSION: Genetic components of intelligence affect measured intelligence and educational attainment, which subsequently affect the prevalence of CAD via a series of unfavorable risk factor profiles.
BACKGROUND: Epidemiological studies have shown inverse association between intelligence and coronary artery disease (CAD) risk, but the underlying mechanisms remain unclear. METHODS: Based on 242 SNPs independently associated with intelligence, we calculated the genetic intelligence score (gIQ) for participants from 10 CAD case-control studies (n = 34,083) and UK Biobank (n = 427,306). From UK Biobank, we extracted phenotypes including body mass index (BMI), type 2 diabetes (T2D), smoking, hypertension, HDL cholesterol, LDL cholesterol, measured intelligence score, and education attainment. To estimate the effects of gIQ on CAD and its related risk factors, regression analyses was applied. Next, we studied the mediatory roles of measured intelligence and educational attainment. Lastly, Mendelian randomization was performed to validate the findings. RESULTS: In CAD case-control studies, one standard deviation (SD) increase of gIQ was related to a 5% decrease of CAD risk (odds ratio [OR] of 0.95; 95% confidence interval [CI] 0.93 to 0.98; P = 4.93e-5), which was validated in UK Biobank (OR = 0.97; 95% CI 0.96 to 0.99; P = 6.4e-4). In UK Biobank, we also found significant inverse correlations between gIQ and risk factors of CAD including smoking, BMI, T2D, hypertension, and a positive correlation with HDL cholesterol. The association signals between gIQ and CAD as well as its risk factors got largely attenuated after the adjustment of measured intelligence and educational attainment. The causal role of intelligence in mediating CAD risk was confirmed by Mendelian randomization analyses. CONCLUSION: Genetic components of intelligence affect measured intelligence and educational attainment, which subsequently affect the prevalence of CAD via a series of unfavorable risk factor profiles.
Authors: Martin Hinterseer; Martin Zens; Roland Jean Wimmer; Simon Delladio; Susanne Lederle; Christian Kupatt; Bernd Hartmann Journal: Clin Res Cardiol Date: 2020-05-19 Impact factor: 5.460
Authors: Thomas Münzel; Frank Breuckmann; Stephan Settelmeier; Tienush Rassaf; Evangelos Giannitsis Journal: Clin Res Cardiol Date: 2020-05-31 Impact factor: 5.460
Authors: Timo Siepmann; Annahita Sedghi; Jessica Barlinn; Katja de With; Lutz Mirow; Martin Wolz; Thomas Gruenewald; Sina Helbig; Percy Schroettner; Simon Winzer; Simone von Bonin; Haidar Moustafa; Lars-Peder Pallesen; Bernhard Rosengarten; Joerg Schubert; Andreas Gueldner; Peter Spieth; Thea Koch; Stefan Bornstein; Heinz Reichmann; Volker Puetz; Kristian Barlinn Journal: J Neurol Date: 2020-08-06 Impact factor: 4.849
Authors: José David Torres-Peña; Luis M Pérez-Belmonte; Francisco Fuentes-Jiménez; Mª Dolores López Carmona; Pablo Pérez-Martinez; José López-Miranda; Francisco Javier Carrasco Sánchez; Juan Antonio Vargas Núñez; Esther Del Corral Beamonte; Jeffrey Oskar Magallanes Gamboa; Andrés González García; Julio González Moraleja; Andrés Cortés Troncoso; María Luisa Taboada Martínez; María Del Pilar Del Fidalgo Montero; José Miguel Seguí Ripol; Ricardo Gil Sánchez; Diana Alegre González; Ramon Boixeda; Begoña Cortés Rodríguez; Javier Ena; Gema María García García; Ana Ventura Esteve; José Manuel Ramos Rincón; Ricardo Gómez-Huelgas Journal: Drugs Date: 2021-03-29 Impact factor: 9.546
Authors: Ling Li; Zhifen Chen; Moritz von Scheidt; Shuangyue Li; Andrea Steiner; Ulrich Güldener; Simon Koplev; Angela Ma; Ke Hao; Calvin Pan; Aldons J Lusis; Shichao Pang; Thorsten Kessler; Raili Ermel; Katyayani Sukhavasi; Arno Ruusalepp; Julien Gagneur; Jeanette Erdmann; Jason C Kovacic; Johan L M Björkegren; Heribert Schunkert Journal: Basic Res Cardiol Date: 2022-02-17 Impact factor: 12.416